BRIEF

on SENSORION (EPA:ALSEN)

Sensorion to Present at 59th Inner Ear Biology Workshop

Stock price chart of SENSORION (EPA:ALSEN) showing fluctuations.

Montpellier, September 12, 2024 – Sensorion, a clinical-stage biotechnology company specializing in therapies for hearing loss disorders, announced its participation in the 59th Annual Inner Ear Biology conference in Warsaw, Poland, from September 15-17, 2024.

Dr. Géraldine Petit, Sensorion’s Preclinical Group Leader, will present a poster titled “Multiplexed TMT-based quantitative proteomics identified essential players involved in the mechanism of action of SENS-401 under normal or ototoxic conditions in intact cochlear organ cultures.” This presentation will occur on Monday, September 16, 2024, from 1pm to 2pm CET. The poster will be available on Sensorion’s website after the session.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SENSORION news